A Phase II Study of Chemoradiotherapy With Nimotuzumab in Unresectable Esophageal Cancer
Clinical trial NCT04207918 · COMPLETED
Trial details
- NCT number
- NCT04207918
- Sponsor
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-14
- Primary completion
- 2022-12-30
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.